首页> 外文期刊>American Journal of Infectious Diseases and Microbiology >The Role of APACHE-II Score in Predicting Acinetobacter baumannii Colonization/Infection and Its Antimicrobial Resistance Pattern in Indonesian Teaching Hospital
【24h】

The Role of APACHE-II Score in Predicting Acinetobacter baumannii Colonization/Infection and Its Antimicrobial Resistance Pattern in Indonesian Teaching Hospital

机译:APACHE-II评分在预测鲍曼不动杆菌定植/感染及其抗菌药耐药模式中的作用

获取原文
           

摘要

Background: A first precautionary action against Acinetobacter baumannii (A.baumanii) can be conducted by identifying well-established risk factors of colonization/infection of that pathogen, such as underlying severity of illness. There are hardly any studies regarding the role of APACHE-II score in predicting risk of A.baumannii colonization/infection in Indonesia. Materials and Methods: A retrospective, case control investigation was performed with medical and microbiology records of ICU patients in an Indonesian Teaching Hospital from January 2013 to December 2014. Results: There were 39 patients with A.baumannii colonization/infection and 59 patients with non-A.baumannii colonization/infection enrolled in this study. Patients with A.baumannii colonization/infection had a significantly higher APACHE II score than non-Acinetobacter group, 25.7 and 23.1 (p=0.038), respectively. APACHE II score ≥ 23 had 74.4% sensitivity and 50.8 specificity to A.baumannii colonization/infection [odd ratio (OR) 3.00, 95% confidence interval (CI) 1.24-7.24, p=0.013], on the other hand APACHE II ≥ 27 had a 53.8% sensitivity and 78.0% specificity (OR 3.75, 95% CI 1.57-8.95, p=0.002). The highest susceptibility level of antibiotics against A.baumannii in this study was shown by tigecycline (82.1%) and amikacin (84.6%). Conclusions: APACHE-II score was strongly correlated with A.baumannii colonization/infection and a cut-off value of APACHE II score ≥ 23 may be used to depict increased moderate risk of A.baumannii colonization/infection. While the use carbapenem against A. baumannii infection was not recommended, tigecycline and amikacin may be considered as antibiotics of choice in treating A.baumannii infection in our hospital setting.
机译:背景:针对鲍曼不动杆菌(A.baumanii)的第一个预防措施可通过确定该病原体定植/感染的公认危险因素(例如潜在的疾病严重程度)来进行。几乎没有关于APACHE-II评分在预测印度尼西亚鲍曼不动杆菌定植/感染风险中的作用的研究。材料和方法:回顾性病例对照研究,对2013年1月至2014年12月在印度尼西亚教学医院ICU患者的医学和微生物学记录进行了调查。结果:39例鲍曼不动杆菌定植/感染,59例非鲍曼不动杆菌感染/感染。 -鲍曼不动杆菌定植/感染参与了这项研究。鲍曼不动杆菌定植/感染患者的APACHE II评分显着高于非不动杆菌组,分别为25.7和23.1(p = 0.038)。 APACHE II得分≥23对鲍曼不动杆菌的定植/感染有74.4%的敏感性和50.8的特异性[比值(OR)3.00,95%的置信区间(CI)1.24-7.24,p = 0.013],另一方面,APACHE II≥ 27具有53.8%的敏感性和78.0%的特异性(OR 3.75,95%CI 1.57-8.95,p = 0.002)。替加环素(82.1%)和丁胺卡那霉素(84.6%)显示了本研究中针对鲍曼不动杆菌的最高敏感性。结论:APACHE-II评分与鲍曼不动杆菌定植/感染密切相关,APACHE II评分≥23的临界值可用来描述中等程度的鲍曼不动杆菌定植/感染的风险。尽管不建议使用碳青霉烯类抗鲍曼不动杆菌感染,但在我们的医院环境中,替加环素和丁胺卡那霉素可能被视为治疗鲍曼不动杆菌感染的首选抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号